Gb Sciences is focusing considerable resources on bringing its lead Parkinson's disease formulations to the clinic with promising results; plus, new data validating the efficacy of their novel anxiety formulations and demonstrating the improved stability of their oral nanoparticle-encapsulated chronic pain formulations add value to their drug development pipeline.
Read Press ReleaseWhile traditional eye drop bottles require hand-eye coordination and deliver four to five times more medication than the human eye can hold, the Optejet® dispenser's human-centric design administers an easier, more accurate and appropriate dose directly where it is needed in the eye.
Read Press ReleaseAcquisition allows Pace® to provide regulatory and quality consulting services to support clients throughout the drug development process and improve commercial compliance in FDA-regulated environments.
Read Press ReleaseMissouri's Investment in Critical Infrastructure Strengthens Supply Chains of Essential Products and Creates New Technology Jobs in the State, The Legislation Supports Efforts to Drive National Health Security & Establish Missouri as the U.S. Hub for the Advanced Manufacturing of Essential Medicines
Read Press ReleaseOffering the most accessible ketamine solution on the market, the holistic telehealth protocol is now available to eligible patients in CA, NY, FL and TX following initial $4.6 million raised in seed funding.
Read Press ReleaseTodd Hood, PharmD, MHA, Bruce Valentine, and Tomas Andrade's appointments demonstrate Amplity's commitment to providing biopharmaceutical and device clients with a sophisticated approach to payer engagement.
Read Press ReleaseMedtech, Biotech, and Pharma industries will gather for the Medtech A+ Team - how to do a successful RegA+ for a Medtech company in a different format, with quicker panels and more information
Read Press ReleasePureWay® launches safe and environmentally friendly medical waste solutions for pharmaceutical, biotech and medical device manufacturers.
Read Press ReleaseRecardio Inc., a clinical-stage life science company developing regenerative therapies for cardiovascular diseases, announced that the positive study results of Recardio's Phase 2 clinical study in Acute Myocardial Infarction were presented on Saturday, May 21, 2022, during the Latebreaker Session at the World Congress on Acute Heart Failure 2022 in Madrid.
Read Press ReleaseDr. Andrea Small-Howard explains that Gb Sciences' multicomponent Parkinson's disease therapeutic addresses this multi-factorial neurodegenerative condition using a combination of cannabinoids that are more effective when used together than singularly, as demonstrated in an animal model of the disease.
Read Press ReleasePresident and Chief Science Officer Dr. Andrea Small-Howard stressed the importance of developing their innovative, plant-inspired formulations as a potentially safer alternative to existing opioid-based pain medications.
Read Press ReleasePlant-inspired biopharmaceutical company signs leading contract research organization to help with a go-to-market strategy for its cannabinoid-containing therapy for COVID-related cytokine release syndrome.
Read Press ReleaseENTEXS, a Sacramento-based hemp extraction technology company, announced that their end-to-end solution, including extraction, remediation, and post-processing, will soon be placed in Phetchabun, Thailand, at their customer Herb Treasure's facility.
Read Press ReleaseLuminous Mind Inc. scientists are focused on psychedelic and psychiatric treatments to enhance healthy brain function and to tackle Central Nervous System (CNS) disorders, including depression, PTSD, pain, anxiety, and addiction. These disorders are among the most serious challenges facing humanity today.
Read Press ReleaseLuminous Mind Inc. scientists are focused on psychedelic and psychiatric treatments to enhance healthy brain function and to tackle Central Nervous System (CNS) disorders, including depression, PTSD, pain, anxiety, and addiction. These disorders are among the most serious challenges facing humanity today.
Read Press Release